Viatris Inc

NASDAQ:VTRSUnited States

Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s ARV franchise. The Company’s portfolio comprises approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands and generics, including complex products. The Company operates approximately 30 manufacturing sites worldwide that produce oral solid doses, injectables and complex dosage forms.

Contact Information

Headquarters

1000 Mylan BoulevardCANONSBURG, PA, United States 15317

Phone

724-514-1800

Fax

302-655-5049

Executives

Chairman Emeritus of the Board

Robert Coury

Chief Executive Officer, Director

Scott Smith

Lead Independent Vice Chairman of the Board

Mark Parrish

Chief Financial Officer

Theodora Mistras

Chief Accounting Officer, Corporate Controller

Paul Campbell